Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study
Pina Vegas L, Le Corvoisier P, Penso L, Paul M, Sbidian E, Claudepierre P.
Rheumatology (Oxford). 2021 Jul 9:keab522.
doi: 10.1093/rheumatology/keab522. Online ahead of print.PMID: 34244706.